A mobile infusion pump is used for the constant delivery of a fluid medium. The infusion pump comprises a balloon body for receiving the medium as well as a filling unit and a delivery unit that are in a fluid connection with the balloon body for filling the medium into the balloon body and delivering the medium from the balloon body to a patient. A throttling unit defines a delivery flow rate of the medium. By means of a plurality of continuous longitudinal ribs arranged on a part of the balloon body configured as a tube body, the expansion behavior of the balloon body is improved.

A mobile infusion pump is used for the constant delivery of a fluid medium. The infusion pump comprises a balloon body for receiving the medium as well as a filling unit and a delivery unit that are in a fluid connection with the balloon body for filling the medium into the balloon body and delivering the medium from the balloon body to a patient. A throttling unit defines a delivery flow rate of the medium. By means of a plurality of continuous longitudinal ribs arranged on a part of the balloon body configured as a tube body, the expansion behavior of the balloon body is improved.

A fluid injector system (1000) is configured to perform an injection protocol. The fluid injector system includes a housing (11) and a controller (900) operatively associated with a user input device (40) and a fluid actuator (16). The controller includes at least one processor programmed or configured to determine an orientation of the housing, receive at least one signal from the user input device, determine a direction of fluid actuation based on the orientation of the housing and the at least one signal, and actuate the fluid actuator in the direction of fluid actuation. The direction of fluid actuation corresponds to at least one of actuating the fluid actuator to inject fluid from a fluid reservoir and actuating the fluid actuator to draw fluid into the fluid reservoir.

A fluid injector system (1000) is configured to perform an injection protocol. The fluid injector system includes a housing (11) and a controller (900) operatively associated with a user input device (40) and a fluid actuator (16). The controller includes at least one processor programmed or configured to determine an orientation of the housing, receive at least one signal from the user input device, determine a direction of fluid actuation based on the orientation of the housing and the at least one signal, and actuate the fluid actuator in the direction of fluid actuation. The direction of fluid actuation corresponds to at least one of actuating the fluid actuator to inject fluid from a fluid reservoir and actuating the fluid actuator to draw fluid into the fluid reservoir.

Embodiments provide devices, preparations and methods for delivering therapeutic agents (TAs) such as clotting factors (CFs, e.g., Factor 8) within the GI tract. Many embodiments provide a swallowable device e.g., a capsule for delivering TAs into the intestinal wall (IW). Embodiments also provide TA preparations configured to be contained within the capsule, advanced from the capsule into the IW and/or surrounding tissue (ST) and degrade to release the TA into the bloodstream to produce a therapeutic effect (e.g., improved clotting). The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW or ST (e.g., the peritoneal cavity). Embodiments are particularly useful for delivery of CFs for treatment of clotting disorders (e.g., hemophilia) where such CFs are poorly absorbed and/or degraded within the GI tract.

Embodiments provide devices, preparations and methods for delivering therapeutic agents (TAs) such as clotting factors (CFs, e.g., Factor 8) within the GI tract. Many embodiments provide a swallowable device e.g., a capsule for delivering TAs into the intestinal wall (IW). Embodiments also provide TA preparations configured to be contained within the capsule, advanced from the capsule into the IW and/or surrounding tissue (ST) and degrade to release the TA into the bloodstream to produce a therapeutic effect (e.g., improved clotting). The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW or ST (e.g., the peritoneal cavity). Embodiments are particularly useful for delivery of CFs for treatment of clotting disorders (e.g., hemophilia) where such CFs are poorly absorbed and/or degraded within the GI tract.

The present disclosure relates to wearable injection devices that comprise flexible elements. Exemplary devices can comprise flexible reservoirs, flexible housings, and flexible metering mechanisms. The flexible elements of the present disclosure provide improved wearable injection devices with small heights, low profiles, and streamlined, flexible cases that can withstand impact without experiencing adverse performance effects or tearing off of the patient.

The present disclosure relates to wearable injection devices that comprise flexible elements. Exemplary devices can comprise flexible reservoirs, flexible housings, and flexible metering mechanisms. The flexible elements of the present disclosure provide improved wearable injection devices with small heights, low profiles, and streamlined, flexible cases that can withstand impact without experiencing adverse performance effects or tearing off of the patient.

A drug delivery device having a central axis, the drug delivery device comprising: a first body part; a first attachment part attached to the first body part and having a first distal end; a second attachment part having a second distal end; and an actuator mechanism configured to move the first distal end towards the second distal end.

The present disclosure relates to a medicament delivery device. The medicament delivery device comprises a housing, a needle and a reservoir. The needle is configured to project from a distal end of the housing. The reservoir is disposed in the housing and has a flexible wall. The medicament delivery device further comprises a dispensing member and a biasing member. The dispensing member is disposed in the housing and the biasing member is configured to bias the dispensing member to move in an arcuate path relative to the housing such that the dispensing member moves across the flexible wall of the reservoir to dispense medicament from the reservoir when the reservoir contains medicament.